Caricamento...
Is There a Place for Immunotherapy for Metastatic Microsatellite Stable Colorectal Cancer?
Immunotherapy using checkpoint inhibitor targeting PD-1 and PD-L1 revolutionized the treatment of microsatellite instable metastatic colon cancer. Such treatment is now a standard of care for these patients. However, when used as monotherapy checkpoint inhibitors targeting PD-1 and PD-L1 are not eff...
Salvato in:
| Pubblicato in: | Front Immunol |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Frontiers Media S.A.
2019
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6691024/ https://ncbi.nlm.nih.gov/pubmed/31447840 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2019.01816 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|